FDA Drug Application (202032) for LAMIVUDINE by AUROBINDO PHARMA LTD

Back to FDA Applications sponsored by AUROBINDO PHARMA LTD

Application Number202032
Product Number001
FormTABLET;ORAL
Dosage150MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLAMIVUDINE
Active IngredientLAMIVUDINE

Active IngredientCount
List of drugs with Active Ingredient LAMIVUDINE39


Back to FDA Applications sponsored by AUROBINDO PHARMA LTD